Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labour: a randomised controlled trial of obstetric and neonatal outcomes
- 19 October 2010
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 284 (3) , 559-565
Abstract
The purpose of this pilot study was to determine the role of foetal fibronectin (fFN) testing in women presenting to hospital with symptoms of preterm labour in reducing the hospital admissions, without significantly increasing the risk of preterm birth and neonatal respiratory distress syndrome.Keywords
This publication has 8 references indexed in Scilit:
- Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care centerAmerican Journal of Obstetrics and Gynecology, 2004
- Fetal fibronectin: The impact of a rapid test on the treatment of women with preterm labor symptomsAmerican Journal of Obstetrics and Gynecology, 2003
- Factors associated with success of emergent second-trimester cerclageObstetrics & Gynecology, 2003
- Accuracy of the Rapid Fetal Fibronectin TLi System in Predicting Preterm DeliveryClinical Chemistry, 2003
- Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic reviewBMJ, 2002
- Predicting preterm birth: A cost-effectiveness analysisAmerican Journal of Obstetrics and Gynecology, 2000
- The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savingsAmerican Journal of Obstetrics and Gynecology, 2000
- Impact of the fetal fibronectin assay on admissions for preterm laborAmerican Journal of Obstetrics and Gynecology, 1999